Cleopatra Hospital Co (CAI:CLHO)

E£ 6.63 0.03 (0.45%) Market Cap: 9.58 Bil Enterprise Value: 10.49 Bil PE Ratio: 22.86 PB Ratio: 3.93 GF Score: 75/100

Q1 2022 Cleopatra Hospital SAE Earnings Call Transcript
May 30, 2022

E£5.34 (+0.19%)

Earnings
Q4 2021 Cleopatra Hospital SAE Earnings Call Transcript
Mar 21, 2022

E£4.69 (+1.96%)

Earnings
Q3 2021 Cleopatra Hospital SAE Earnings Call Transcript
Nov 22, 2021

E£4.8 (+0.21%)

Earnings
Q2 2021 Cleopatra Hospital SAE Earnings Call Transcript
Aug 30, 2021

E£4.65 (+4.73%)

Earnings
Q1 2021 Cleopatra Hospital SAE Earnings Call Transcript
Jun 07, 2021

E£4 (+0.50%)

Earnings
Q4 2020 Cleopatra Hospital SAE Earnings Call Transcript
Mar 22, 2021

E£4.5

Earnings
Alameda Group, Cleopatra Hospital Group S.A.E. - M&A Call Transcript
Jan 11, 2021
Q2 2020 Cleopatra Hospital SAE Earnings Call Transcript
Sep 07, 2020

E£4.78 (-0.42%)

Earnings
Q1 2020 Cleopatra Hospital SAE Earnings Call Transcript
Jun 22, 2020

E£5.14 (+2.59%)

Earnings
Q4 2019 Cleopatra Hospital SAE Earnings Call Transcript
Mar 16, 2020

E£4.2 (-8.50%)

Earnings
Q3 2019 Cleopatra Hospital SAE Earnings Call Transcript
Nov 25, 2019

E£6.02 (-0.66%)

Earnings
Q2 2019 Cleopatra Hospital Earnings Call Transcript
Sep 09, 2019

E£6.04 (-3.36%)

Earnings
Q1 2019 Cleopatra Hospital Earnings Call Transcript
Jun 10, 2019

E£6.5 (+3.17%)

Earnings

Alameda Group, Cleopatra Hospital Group S.A.E. - M&A Call Transcript

Jan 11, 2021 / 02:00PM GMT

Release Date Price: E£4.96 (+3.33%)

Transcript

Hatem Alaa

EFG Hermes Holding S.A.E., Research Division - MD & Head of Consumer and Healthcare

Hello, everyone. This is Hatem Alaa from EFG Hermes, and welcome to Cleopatra Hospitals Group (sic) [Cleopatra Hospital Group] conference call to discuss the Alameda Group acquisition. I'm pleased to have on the call today from the company, Ahmed Badreldin, Chairman; Dr. Ahmed Ezz El-Din, CEO; and Hassan Fikry, Corporate Strategy and Investor Relations Director.

I'll now hand over the call to management for presentation. Gentlemen, please go ahead.

Ahmed Adel Badreldin

Cleopatra Hospital Group S.A.E. - Chairman of the Board

Okay. I'll kick off. Thank you very much, everyone, for joining us on this call. Hassan, if we can move to the first slide.

So on this slide, we'll just recap CHG's mission and values. For us, it's all about the patient. We put our patients first by providing high-quality health care with a focus on patient safety and quality of outcomes while enhancing the quality of life of our patients.

The journey for us with

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.